TD Cowen Starts Braveheart Bio (BRVE) at Buy Aug 31, 2026 05:29AM
Braveheart Bio raises $439.9M in upsized Nasdaq IPO Aug 7, 2026 04:05PM
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Aug 7, 2026 04:05PM
Braveheart Bio prices IPO at $18 per share, raises $382.5M Aug 5, 2026 10:33PM
Braveheart Bio Announces Pricing of Upsized Initial Public Offering Aug 5, 2026 10:33PM


Jul 30, 2026 06:19AM Braveheart Bio targets up to $318.8M in US IPO
Jul 15, 2026 06:06AM Braveheart Bio files for Nasdaq IPO under ticker BRVE